Home Affymetrix

Affymetrix

acquired
IPO Delisting
Biotechnology R&D Developer

Basic Information

Affymetrix is a biotechnology company dedicated to developing innovative technologies that support multiplex and parallel analysis of cellular biosystems, thereby promoting the rapid translation of results into biology that contributes to a better world. Affymetrix products, tools, and resources that assist researchers through microarray analysis benefit application areas such as plant and animal genomics and transcriptomics, including multidisciplinary basic research and industry applications like breeding, population diversity and conservation, and trait analysis. The company’s unique solutions are also applicable to cancer research from discovery to clinical research and validation, such as cytogenetic studies of reproductive genetic disorders and cancer diseases. Research on the genetics of human complex traits, Mendelian diseases, and populations is another area where Affymetrix microarray analysis can advance application testing, for example, by enabling human genetic research workflows through population-optimized and application-optimized genotyping.
Affymetrix
SanDiego,California,United States of America
more than 500 people
January 01, 1991
corporate1@affymetrix.com